Researcher
Inge Oudaert
- Keywords:Medicine
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From16 Aug 2019 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From26 Sep 2015 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Nov 2023 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Nov 2019 → 31 Oct 2023 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jul 2019 → 31 Dec 2019 - Faculty of Medicine and Pharmacy (Faculty)
Member
From16 Feb 2016 → 26 Jun 2019
Projects
1 - 1 of 1
- Targeting the hypoxia-induced metabolic changes in multiple myeloma to conquer drug resistance.From1 Oct 2019 → 31 Jan 2024Funding: FWO fellowships
Publications
1 - 6 of 6
- Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer(2023)
Authors: Lisa Kerkhove, Febe Geirnaert, Amir Laraki Rifi, Ka Lun Law, Adrian Gutierrez, Inge Oudaert, Cyril Corbet, Thierry Gevaert, Inès Dufait, Mark De Ridder
- Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis(2023)
Authors: Arne Van der Vreken, Inge Oudaert, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Ann Massie, Kim De Veirman, et al.
Pages: 112-123 - Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism(2023)
Authors: Hatice Satilmis, Emma Verheye, Philip Vlummens, Inge Oudaert, Niels Vandewalle, Rong Fan, Jennifer M Knight, Nathan De Beule, Gamze Ates, Ann Massie, et al.
Pages: 69–80 - System Xc- inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance(2022)
Authors: Fang Wang, Inge Oudaert, Chenggong Tu, Anke Maes, Arne Van der Vreken, Philip Vlummens, Elke De Bruyne, Kim De Veirman, Yanmeng Wang, Rong Fan, et al.
- Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Authors: Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, et al.
Pages: 45 - Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma(2022)
Authors: Esther Zaal, Harm Jan De Groot, Inge Oudaert, Eline Menu, Celia R. Berkers
Pages: 19-30